Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment

Inclusion Criteria: * Male or female, aged 21 to 65 years. * Subject in good health. * Fitzpatrick skin classification type 1-5. * Striae rubra and alba on the abdomen. * Understands and accepts the obligation not to undergo any other procedures in the area(s) to be treated through the follow-up period. * Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study. * Absence of physical or psychological conditions unacceptable to the investigator. * Willingness and ability to provide written consent for study-required photography and adherence to photography requirements . * Willingness and ability to provide written informed consent and HIPAA authorization prior to performance of any study-related procedure. * Subjects of childbearing potential must have a negative urine pregnancy test result and must not be lactating at Visit 1 and be willing and able to use an acceptable method of birth control during the study Exclusion Criteria: * Presence of an active systemic or local skin disease that may affect wound healing. * Current bacterial or viral infection in the area to be treated. * Severe solar elastosis. * Significant scarring or burns in area(s) to be treated. * Prior radiation therapy in the area(s) to be treated. * Open wounds or lesions in the area(s) to be treated. * History of keloid or hypertrophic scarring * History of irregular pigmentation of the skin, Lichens Planus, Vitiligo or Psoriasis in the treatment area that in the investigators opinion, would put the subject at unnecessary risk. * Inability to understand the protocol or to give informed consent. * Microdermabrasion, or prescription level glycolic acid treatments to the intended treatment area(s) within two weeks prior to study participation or during the study. * History of chronic drug or alcohol abuse. * History of autoimmune disease. * Concurrent therapy that, in the investigator's opinion, would interfere with the evaluation of the safety or efficacy of the study device. * Subjects who anticipate the need for surgery or overnight hospitalization during the study. * Subjects who, in the investigator's opinion, have a history of poor cooperation,noncompliance with medical treatment, or unreliability. * Concurrent enrollment in any study involving the use of investigational devices or drugs. * Current smoker or history of smoking in the last five years. * History of prior abdominal Suction Assisted Lipectomy or Abdominoplasty. * History of prior Massive Weight Loss * History of using the following prescription medications: 1. Accutane or other systemic retinoids within the past 12 months; 2. Antiplatelet agents / Anticoagulants (Coumadin, Heparin, Plavix); 3. Psychiatric drugs that in the investigators opinion would impair the subject from understanding the protocol requirements or understanding and signing informed consent.